메뉴 건너뛰기




Volumn 243, Issue 1-2, 2006, Pages 97-99

Antimyoclonic effect of levetiracetam in MERRF syndrome

Author keywords

Levetiracetam; MERRF; Myoclonus; PME

Indexed keywords

ETIRACETAM; PHENYLALANINE; TRANSFER RNA; UBIDECARENONE; VALPROIC ACID;

EID: 33645079375     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2005.11.021     Document Type: Article
Times cited : (47)

References (10)
  • 1
    • 15044357259 scopus 로고    scopus 로고
    • Progressive myoclonic epilepsies: A review of genetic and therapeutic aspects
    • A. Shahwan, M. Farrell, and N. Delanty Progressive myoclonic epilepsies: a review of genetic and therapeutic aspects Lancet Neurol 4 2005 239 248
    • (2005) Lancet Neurol , vol.4 , pp. 239-248
    • Shahwan, A.1    Farrell, M.2    Delanty, N.3
  • 2
    • 0036372802 scopus 로고    scopus 로고
    • Clinical features and genetics of myoclonic epilepsy with ragged red fibers
    • S. DiMauro, M. Hirano, P. Kaufmann, K. Tanji, M. Sano, and D.C. Shungu Clinical features and genetics of myoclonic epilepsy with ragged red fibers Adv Neurol 89 2002 217 229
    • (2002) Adv Neurol , vol.89 , pp. 217-229
    • Dimauro, S.1    Hirano, M.2    Kaufmann, P.3    Tanji, K.4    Sano, M.5    Shungu, D.C.6
  • 3
  • 4
    • 2342584598 scopus 로고    scopus 로고
    • Mitochondrial encephalomyopathies: Therapeutic approach
    • S. Dimauro, M. Mancuso, and A. Naini Mitochondrial encephalomyopathies: therapeutic approach Ann N Y Acad Sci 1011 2004 232 245
    • (2004) Ann N Y Acad Sci , vol.1011 , pp. 232-245
    • Dimauro, S.1    Mancuso, M.2    Naini, A.3
  • 6
    • 32344434388 scopus 로고    scopus 로고
    • Myoclonic epilepsy and ragged-red fibers (MERRF): A mitochondrial tRNALys mutation responsive to Coenzyme Q10 (CoQ) therapy (abs)
    • D.C. Wallace, J.M. Shoffner, M.T. Lott, and L.C. Hopkins Myoclonic epilepsy and ragged-red fibers (MERRF): a mitochondrial tRNALys mutation responsive to Coenzyme Q10 (CoQ) therapy (abs) Neurology 41 2000 280
    • (2000) Neurology , vol.41 , pp. 280
    • Wallace, D.C.1    Shoffner, J.M.2    Lott, M.T.3    Hopkins, L.C.4
  • 7
    • 0034489874 scopus 로고    scopus 로고
    • Antimyoclonic effect of levetiracetam
    • P. Genton, and P. Gelisse Antimyoclonic effect of levetiracetam Epil Dis 2 2000 209 212
    • (2000) Epil Dis , vol.2 , pp. 209-212
    • Genton, P.1    Gelisse, P.2
  • 8
    • 3042689878 scopus 로고    scopus 로고
    • Antimyoclonic effect of levetiracetam in 13 patients with Unverricht-Lundborg disease: Clinical observations
    • A. Magaudda, P. Gelisse, and P. Genton Antimyoclonic effect of levetiracetam in 13 patients with Unverricht-Lundborg disease: clinical observations Epilepsia 45 2004 678 681
    • (2004) Epilepsia , vol.45 , pp. 678-681
    • Magaudda, A.1    Gelisse, P.2    Genton, P.3
  • 9
    • 1342266966 scopus 로고    scopus 로고
    • Levetiracetam in progressive myoclonic epilepsy: An exploratory study in 9 patients
    • C. Crest, S. Dupont, E. Leguern, C. Adam, and M. Baulac Levetiracetam in progressive myoclonic epilepsy: an exploratory study in 9 patients Neurology 62 2004 640 643
    • (2004) Neurology , vol.62 , pp. 640-643
    • Crest, C.1    Dupont, S.2    Leguern, E.3    Adam, C.4    Baulac, M.5
  • 10
    • 14044278910 scopus 로고    scopus 로고
    • Limited efficacy of levetiracetam on myoclonus of different etiologies
    • L.L. Lim, and A. Ahmed Limited efficacy of levetiracetam on myoclonus of different etiologies Parkinsonism Relat Disord 11 2005 135 137
    • (2005) Parkinsonism Relat Disord , vol.11 , pp. 135-137
    • Lim, L.L.1    Ahmed, A.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.